189
Participants
Start Date
January 23, 2015
Primary Completion Date
July 14, 2017
Study Completion Date
July 14, 2017
Presatovir
Presatovir 200 mg (4 × 50 mg tablets) administered orally or via nasogastric (NG) tube
Placebo
Tablets administered orally or via nasogastric tube
Mayo Clinic Arizona, Phoenix
City of Hope, Duarte
UCLA David Geffen School of Medicine, Los Angeles
Stanford University, Stanford
Emory University, Atlanta
NorthSide Medical Center, Atlanta
Northwestern University, Chicago
University of Chicago, Chicago
Loyola University, Maywood
John Hopkins, Baltimore
Dana Farber Cancer Institute, Boston
University of Massachusetts Memorial Cancer Center, Boston
University of Michigan, Ann Arbor
Wayne State University, Detroit
University of Minnesota, Minneapolis
Washington University, St Louis
Memorial Sloan Kettering, New York
New York Presbyterian Hospital Cornell Medical Center, New York
Duke University, Durham
University Hospital Case Medical, Cleveland
Oregon Health Sciences University, Portland
Vanderbilt University Medical Center, Nashville
MD Anderson Cancer Center, Houston
Texas Transplant Institute (SCRI), San Antonio
University of Utah, Salt Lake City
Fred Hutchison Cancer Research Center, Seattle
Medical College of Wisconsin, Milwaukee
Westmead Hospital, Westmead
Royal Brisbane & Women's Hospital, Herston
Royal Melbourne Hospital, Melbourne
Hospital de Clínicas de Porto Alegre, Porto Alegre
Fundacao Faculdade Regional Medicina de Sao Jose do Rio Preto, São Paulo
Fundação Antonio Prudente - Hospital do Câncer AC Camargo, São Paulo
Hospital Israelita Albert Einstein, São Paulo
Hospital Santa Marcelina, São Paulo
Hospital Universitario USP, São Paulo
Instituto Brasileiro de Controle do Câncer-IBCC, São Paulo
Hopital Maisonneuve-Rosemont, Montreal
Tom Baker Cancer Centre, Calgary
CHU de Bordeaux, Bordeaux
Hopital Saint-Louis, APHP, Paris
Hopital Foch, Suresnes
Institut Universitaire du Cancer Oncopole, Toulouse
Universitatsklinikum Wurzburg, Würzburg
Soroka Medical Center, Beersheba
Rambam Medical Center, Haifa
Hadassah Medical Center, Jerusalem
Rabin Medical Center, Petah Tikva
Chaim Sheba Medical Center, Ramat Gan
Tel Aviv Sourasky Medical Center, Tel Aviv
VUmc cancer center, Amsterdam
Erasmus Medical Center (Rotterdam), Rotterdam
Singapore General Hospital, Singapore
UMC National University Health System, Singapore
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Seoul Saint Mary's Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Hospital universitario Virgen del Rocio, Seville
Karolinska Institutet, Stockholm
University Clinic Basel, Basel
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
China Medical University Hospital, Taichung
National Taiwan University Hospital, Taipei
Chang Gung Medical Foundation-LinKou Branch, Taoyuan District
Leeds Teaching Hospitals Trust, Leeds
King's College Hospital, London
Lead Sponsor
Gilead Sciences
INDUSTRY